In an era where healthcare demands are evolving rapidly, the global medical bed market is on an impressive growth trajectory. According to recent projections, this market is expected to exceed USD ...

REDWOOD CITY, CA / ACCESSWIRE / November 5, 2024 / Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research ...

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that after more than 30 years of leadership, W. Andrew "Andy" Adams has notified the Board ...

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.90 per common share on January 29, 2025 ...

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2024.Financial Results and ...

CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at ...

Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies, announces further promising data from the fully enrolled Phase 1b/2 study ...

LEWES, DE / ACCESSWIRE / November 5, 2024 / Beebe Healthcare has partnered with Sublimation Health to transform its digital landscape with an Epic Electronic Health Record (EHR) system hosted on ...

SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, ...

Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Dr. Lara Boyd as Chief Business Officer.

Award Recognizes Vheda Health's Commitment to Excellence in Transforming Health Outcomes for Centene's Underserved PopulationsCOLUMBIA, MD. / ACCESSWIRE / November 5, 2024 / Vheda Health, a leader in ...